Drug controller okays Psoriasis injection for COVID-19 patients

India's drug regulator has approved Itolizumab, used to cure skin ailment psoriasis, for restricted emergency use on COVID-19 patients with moderate to severe acute respiratory distress, officials......

Serum Institute gets nod to resume vaccine trial in India

Drugs Controller General of India Dr V G Somani on Tuesday gave permission to Serum Institute of India to resume clinical trial of the Oxford COVID-19 vaccine candidate in the country while......

Uzbek syrup deaths: India begins probe, manufacturing halted

The manufacturing of Marion Biotech's Dok-1 Max has stopped “for now”, the company's legal representative said on Thursday as the Central Drugs Standard Control Organisation began a......

DCGI orders Serum to suspend recruitment for COVID-19 vaccine trials

Drugs Controller General of India has directed Serum Institute of India to suspend till further orders new recruitment in phase 2 and 3 clinical trials of the Oxford COVID-19 vaccine candidate in......